Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the detailed record of transactions filed by Sayer Kevin R, Director General. Director active across 1 company, notably DEXCOM INC. Aggregated, 32 reports have been published. Split: 0 buy · 21 sells. Total volume traded: €31.7m. History available since 3 May 2021. The latest transaction was filed on 20 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Sayer Kevin R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3000 títulos@ 438,81 US$3.7% de su flujoCommon StockSEC:0001093557-22-000002:0
25 de 32 declaraciones
About Sayer Kevin R
SAYER KEVIN R is Directeur Général and Executive Chair at DEXCOM INC (XNAS). He has filed 28 reports in total, and across the 28 sampled filings between 2016-01-22 and 2026-07-07, the transactions are all sales, with a combined amount of EUR 29660082; the largest reported filings concern DEXCOM INC, including EUR 4652686.856127085 on 2023-01-31, EUR 4451655.710971985 on 2023-01-24, EUR 3648805.579981526 on 2024-03-14, EUR 3463370.676503722 on 2024-04-10, EUR 3239866.470154298 on 2023-03-02, and EUR 2095635.613607376 on 2025-03-14.